BI-L 357 is a prodrug of BL-L 226 and is a selective & orally bioavailable 5-lipoxygenase inhibitor. References: Farina PR, Graham AG, Homon CA, Lazer ES, Hattox SE, Riska PS, Gundel RH, Wegner CD. A prodrug of a 2,6-disubstituted 4-(2-arylethenyl)phenol is a selective and orally active 5-lipoxygenase inhibitor. J Pharmacol Exp Ther. 1993 May;265(2):483-9. PubMed PMID: 8388452.

纯度：≥98%

CAS：149539-02-6